Jade Biosciences, Inc.

Nasdaq:JBIO

Pharmaceutical Preparations·WALTHAM, MA

Jade is an umbrella term for two different types of decorative rocks used for jewelry or ornaments. Jade is often referred to by either of two different silicate mineral names: nephrite, or jadeite.

Financials

19 shown

Type	Period	Ended	Filed
10-K	FY 2025	12/31/25	3/6/26	→
10-Q	Q3 2025	9/30/25	11/14/25	→
10-Q	Q2 2025	6/30/25	8/13/25	→
10-Q	Q1 2025	3/31/25	4/25/25	→
10-K	FY 2024	12/31/24	3/27/25	→
10-Q	Q3 2024	9/30/24	11/12/24	→
↓

Earnings Releases (8-K)

18 shown

Filed	Period
3/6/26	Q1 FY2026	→
1/5/26	Q4 FY2026	→
11/14/25	Q4 FY2025	→
8/13/25	Q3 FY2025	→
5/14/25	Q2 FY2025	→
5/1/25	Q1 FY2025	→
↓

News (8-K)

32 shown

Filed	Type	Description
12/15/25	Agreement	Entry into a Material Definitive Agreement	→
10/7/25	Agreement	Entry into a Material Definitive Agreement	→
9/9/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
7/1/25	Exec Change	Entry into a Material Definitive Agreement	→
4/29/25	Reg FD	Regulation FD Disclosure	→
4/23/25	Other	Other Events	→
↓

Prospectuses & Registrations

30 shown

Filed	Form	Description
3/6/26	S-8	S-8	→
3/6/26	424B3	424B3	→
3/6/26	424B3	424B3	→
12/30/25	424B3	424B3	→
12/22/25	S-1	S-1	→
12/19/25	424B3	424B3	→
↓

Filing History(459 filings)

TypeDateAccessionPeriodSize

S-8

Mar 6, 2026

0001193125-26-096771S-8

—

183.1 KB

POS EX

Mar 6, 2026

0001193125-26-096706POS EX

—

30.5 KB

POS EX

Mar 6, 2026

0001193125-26-096696POS EX

—

29.7 KB

424B3

Mar 6, 2026

0001193125-26-096623424B3

—

9.5 MB

424B3

Mar 6, 2026

0001193125-26-096618424B3

—

9.5 MB

10-K

Mar 6, 2026

0001193125-26-09655010-K

Dec 31, 2025

24.6 MB

8-K

Mar 6, 2026

0001193125-26-0949678-K

Mar 6, 2026

207.1 KB

SCHEDULE 13D/A

Mar 5, 2026

0001104659-26-023732

—

39.5 KB

SCHEDULE 13G/A

Feb 17, 2026

0001738048-26-000022

—

18.5 KB

SCHEDULE 13G

Feb 17, 2026

0001104659-26-016343

—

9.1 KB

SCHEDULE 13G

Feb 17, 2026

0001274173-26-000080

—

12.1 KB

Feb 13, 2026

0001193125-26-0520564

Feb 12, 2026

7.3 KB

Feb 13, 2026

0001193125-26-0520554

Feb 12, 2026

7.4 KB

Feb 13, 2026

0001193125-26-0520544

Feb 12, 2026

7.5 KB

Feb 13, 2026

0001193125-26-0520534

Feb 12, 2026

7.4 KB

SCHEDULE 13G/A

Feb 13, 2026

0001172661-26-000717

—

11.2 KB

SCHEDULE 13G/A

Jan 30, 2026

0000102909-26-000167

—

7.0 KB

8-K

Jan 5, 2026

0001193125-26-0015028-K

Jan 5, 2026

188.9 KB

EFFECT

Dec 30, 2025

9999999995-25-003970

—

1.8 KB

424B3

Dec 30, 2025

0001193125-25-337047424B3

—

6.4 MB

S-1

Dec 22, 2025

0001193125-25-328848S-1

—

18.4 MB

EFFECT

Dec 19, 2025

9999999995-25-003855

—

1.8 KB

424B3

Dec 19, 2025

0001193125-25-326940424B3

—

6.4 MB

8-K

Dec 15, 2025

0001193125-25-3184368-K

Dec 13, 2025

504.3 KB

SCHEDULE 13G/A

Nov 14, 2025

0001231919-25-000494

—

34.3 KB

25 filings shown

Filed	Form	Description
4/26/24	DEFA14A	DEFA14A	→
4/26/24	DEF 14A	DEF 14A	→
4/19/23	DEFA14A	DEFA14A	→
4/19/23	DEF 14A	DEF 14A	→
4/29/22	DEFA14A	DEFA14A	→
4/29/22	DEF 14A	DEF 14A	→

Jade Biosciences, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(459 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
2/13/26	4	4	→
2/13/26	4	4	→
2/13/26	4	4	→
2/13/26	4	4	→
10/8/25	4	OWNERSHIP DOCUMENT	→
7/14/25	4	4	→
↓